We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$243B
AUM Growth
+$27.2B
Cap. Flow
+$15.3B
Cap. Flow %
6.3%
Top 10 Hldgs %
14.51%
Holding
8,546
New
751
Increased
3,655
Reduced
3,102
Closed
634

Sector Composition

Rank Sector Weight
1 Financials 7.78%
2 Technology 7.19%
3 Healthcare 5.6%
4 Industrials 5.06%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KELYB
7026
Kelly Services Class B
KELYB
$765M
$9K ﹤0.01%
345
+5
+1% +$140
LX
7027
LexinFintech Holdings
LX
$241M
$9K ﹤0.01%
+675
New +$8.93K
MHH icon
7028
Mastech Digital
MHH
$93.1M
$9K ﹤0.01%
1,834
-962
-34% -$5.31K
MRKR icon
7029
Marker Therapeutics
MRKR
$18.8M
$9K ﹤0.01%
236
+30
+15% +$921
NAAS
7030
NaaS Technology Inc
NAAS
$55.1M
0
NODK icon
7031
NI Holdings
NODK
$310M
$9K ﹤0.01%
506
+169
+50% +$2.96K
OTLK icon
7032
Outlook Therapeutics
OTLK
$183M
$9K ﹤0.01%
43
+28
+187% +$5.81K
OTRK
7033
DELISTED
Ontrak
OTRK
$9K ﹤0.01%
+27
New +$9.13K
PHIO icon
7034
Phio Pharmaceuticals
PHIO
$11.8M
0
RFIL icon
7035
RF Industries
RFIL
$134M
$9K ﹤0.01%
3,357
+2,357
+236% +$5.76K
STRA icon
7036
Strategic Education
STRA
$1.85B
$9K ﹤0.01%
104
-3,411
-97% -$315K
STRM
7037
DELISTED
Streamline Health Solutions
STRM
$9K ﹤0.01%
+369
New +$8.47K
SYPR icon
7038
Sypris Solutions
SYPR
$42.8M
$9K ﹤0.01%
6,488
+1,058
+19% +$1.53K
TANH icon
7039
Tantech Holdings
TANH
$6.07M
0
TWN
7040
Taiwan Fund
TWN
$471M
$9K ﹤0.01%
447
UTES icon
7041
Virtus Reaves Utilities ETF
UTES
$1.33B
$9K ﹤0.01%
+272
New +$9.11K
VTC icon
7042
Vanguard Total Corporate Bond ETF
VTC
$1.72B
$9K ﹤0.01%
+100
New +$8.48K
ITCI
7043
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$9K ﹤0.01%
600
-10,560
-95% -$163K
DXYN
7044
DELISTED
Dixie Group Inc
DXYN
$9K ﹤0.01%
+2,252
New +$8.78K
SCTL
7045
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$9K ﹤0.01%
1,032
+422
+69% +$3.46K
FRTX
7046
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$9K ﹤0.01%
15
-4
-21% -$2.64K
MTEM
7047
DELISTED
Molecular Templates, Inc.
MTEM
$9K ﹤0.01%
61
+49
+408% +$6.15K
FUE
7048
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Biofuels Total Return
FUE
$9K ﹤0.01%
1,315
-400
-23% -$2.85K
BDR
7049
DELISTED
Blonder Tongue Laboratories Inc
BDR
$9K ﹤0.01%
14,675
+5,352
+57% +$2.57K
CALA
7050
DELISTED
Calithera Biosciences, Inc
CALA
$9K ﹤0.01%
53
-1,998
-97% -$512K

Similar funds

UBS Group's Q4 2017 Portfolio in Review

As of Q4 2017, UBS Group held 8,546 positions worth $243B, up 13% from $216B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group deployed $15.3B of net new capital in Q4 2017, opening 751 new positions and adding to 3,655 existing holdings. Its largest new stake was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.22B trimmed.

  • UBS Group's largest Q4 2017 buy was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
  • UBS Group added most to Apple in Q4 2017, an estimated $602M increase.
  • UBS Group's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.22B.
  • UBS Group fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $139M.
  • UBS Group's ten largest holdings make up 15% of its $243B portfolio in Q4 2017.
  • UBS Group opened 751 new positions and closed 634 in Q4 2017.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $243B.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.